COPD therapeutics Flashcards

1
Q

What does the mMRC questionnaire ask for?

A

Description of breathlessness after exercise or normal activity
- Dyspnea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What factors are in the COPD assessment test (CAT)?

A

Both respiratory symptoms and functioning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define group A COPD characteristics
Exacerbations?
mMRC score
CAT score

A

Exacerbations?
- 0 or 1 NOT LEADING TO HOSPITAL

mMRC score: 0-1
CAT score: under 10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define group B COPD characteristics
Exacerbations?
mMRC score
CAT score

A

Exacerbations?
- 0 or 1 NOT LEADING TO HOSPITAL

mMRC score: 2+
CAT score: 10+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define group E COPD characteristics
Exacerbations?
mMRC score
CAT score

A

Exacerbations?
- 2+ Moderate exacerbations
- 1+ LEADING TO HOSPITAL

mMRC score: 2+
CAT score: 10+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the BODE index used for? What are the factors?

A

To predict mortality
B= BMI
O = obstruction (FEV1)
D = Dyspnea (mMRC)
E = exercise capacity (distance walked in 6 min)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What do COPD exacerbations look like (3 main symptoms)

A

Acute changes in:
1. Cough increases in frequency + severity
2. Sputum production inc in volume / character
3. Dyspnea increases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the therapeutic strategies level in COPD (5)

A
  1. Smoking cessation , healthy lifestyle, SABA PRN
  2. Inhaled maintenance/preventative pharmacotherapies
  3. Pulmonary rehab
  4. Other pharmacotherapies
  5. Oxygen +/- NIV (non-invasive ventilation)
  6. Surgical/endoscopic therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When is pulmonary rehab recommended? what group of patients?

A

Prevents hospitalization if initiated less than 4 weeks after an exacerbation
- encouraged for Group B and E patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

SABA (2)
MOA
PD (side effects) (4)
Onset
Duration

A

SABA (2)
1. Salbutamol
2. Terbutaline

PD
- tachycahardia
- tremor
- hypertension
- difficulty sleeping (common)

MOA
- relaxes bronchial smooth muscle

Onset: 1-3 min
Duration: 4-6 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

SAMA (1)
MOA
PD (side effects) (3)
Onset
Duration

A

SAMA (1)
1. Ipratropium

PD
- Headache
- Dry mouth
- UTI

MOA
- Blocks ACh in bronchial smooth muscle
- decrease PSNS activity in lungs
- bronchodilation

Onset: 15 min
Duration: up to 8 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Is SAMA/SABA combo better than SAMA and SABA alone? What combination exists (1)

A

Combo more effective than single therapy
- attacking smooth muscle in 2 different ways

  1. Ipratropium + salbutamol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Can ICS be used alone in COPD?

A

Never

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ICS (5)
MOA
PD (side effects) (3)
Onset
Duration (for clinical benefit)

A

ICS (5)
1. Ciclesonide
2. Mometasone
3. Fluticasone furoate (COPD, more potent) propionate (Asthma)
4. Budesonide
5. Beclomethasone

MOA
- Anti-inflammatory
- Immunosuppressive
- Anti-proliferative

PD (side effects) (3)
- Oral candidiasis
- UTRIs
- Hoarse voice

Onset: 24 hours
Duration: 2-4 weeks for clinical benefit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

LABA (4)
Onset
Duration

A

LABA (4)
1. Formoterol
2. Indacaterol
3. Salmeterol
4. Olodaterol

Onset
1-3 min: Formeterol, indacaterol, olodaterol
30-50 min: Salmeterol

Duration
12 hours: formterol, Salmeterol
24 hours: Indacaterol, olodaterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

LAMA (4)
MOA
Onset
Duration

A

LAMA (4)
1. Tiotropium
2. Glycopyrronium
3. Umeclidinium
4. Aclidinium

MOA
- competitively and reversible inhibition of ACH action at M3 receptors
- causes bronchodilation

Onset
- 15 min: glyco, ulme, aclidi
- 30 min: tio

Duration
- 12 hours: aclid
- 24 hours: Tio, glyco, ulme

**take weeks to get a clinical benefit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the LABA/ICS combo available for COPD? (3)
Which is the only combo with duration of 24 hours?

A
  1. Fluticasone prop/salmeterol ADVAIR diskus
    - generic: WIXELLA
  2. Budesonide/formoterol SYMBICORT
  3. fluticasone furoate/ vilanterol BREO ELIPTA

24 hour duration
- fluticasone furoate / vilanterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the LAMA/LABA combos available (4)

A
  1. ume/vilanterol
  2. Aclidi/ formoterol
  3. Tio/olodaterol
  4. glyco/indacterol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are these groups usually prescribed as initial treatment
Group A
Group B
Group E

A

Group A
- bronchodilator (LAMA is best)

Group B
- LABA/LAMA combo

Group E
- LABA/LAMA combo
- if eosinophils 300+ consider LABA/LAMA/ICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the general rule based on patient’s current long-acting inhaler therapy? (2)

A
  1. Patient can always use a SABA
  2. If a patient on a LAMA –> dont use a SAMA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What do you give if a patient is neither on a LABA or LAMA

A

can give a SABA and/or SAMA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Is SABA/SAMA combo more effective for DYSPNEA for reliever than monotherapy

A

Yes, due to different
- sites of action
- mechanisms of action
- onset/durations of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Group A patients:
1. if they are experiencing only occasional breathlessness (dyspnea) what do you give?
2. What if initial treatment not working?
3. What if frequent use of treatment?

A
  1. Short acting bronchodilator (SABA)
  2. Take duo therapy SABA/SAMA
  3. Choose a LABA or LAMA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Which is better for reducing dyspnea, exacerbations, FEV1, use of salbutamol: LABA or LAMA

A

LAMA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Is LABA effective as monotherapy. What was the outcome?
Yes - decreased exacerbation - decrease use in SABA - improved FEV1
25
Can group A patients that have CV problems/complications start LAMA
Yes
26
In group B patients 1. is LABA/LAMA more effective than LABA 2. Is LABA/LAMA more effective than LAMA
1. Yes 2. No significance
27
Can you use LABA + ICS in group E COPD patients
never - has more side effects than LABA/LAMA
28
What is the best treatment for Group E patients? When should you avoid ICS (3)?
LABA/LAMA/ICS Against use of ICS: - repeated pneumonia events - eosinophils UNDER 100 - History of mycobacterial infection
29
What was the outcome when using LABA/LAMA/ICS against LABA/LAMA? (1)
Triple therapy with high dose ICS reduced ALL-CAUSE MORTALITY compared to duo therapy
30
Can you give triple therapy for patients with eosinophils below <150? Is it more effective than duo therapy?
Yes. - same efficacy as duo therapy in eos <150
31
When is ICS/LABA given? What if their symptoms or exacerbations get worse?
If patient has concomitant asthma - if symptoms or exacerbations get worse, increase ICS/LABA dose or add LAMA
32
What should you do if a COPD patient is on an ICS/LABA WITHOUT asthma
- taper down ICS dose - switch to LABA/LAMA
33
Which more effective at reducing exacerbations in GROUP E/mod-very severe patients: ICS/LABA or LABA
ICS/LABA
34
Steroid use in COPD
Long-term NOT recommended (oral or inhaled) - can use short-term
35
If a patient is suffering from Dyspnea at FOLLOW-UP (not the first ABE treatment) what is the algorithm of treatment (3)
1. LABA or LAMA 2. LABA/LAMA combo 3. Switch LABA/LAMA combinations
36
If a patient is suffering from Exacerbations at FOLLOW-UP (not the initial ABE treatment) what is the algorithm of treatment if on a LABA or LAMA?
1. LABA or LAMA 2. LABA/LAMA if eos <300 2. LABA/LAMA/ICS if eos 300+
37
If a patient is suffering from Exacerbations at FOLLOW-UP (not the initial ABE treatment) what is the algorithm of treatment if on a LABA/LAMA combo + eos <100 or 100+?
LABA/LAMA + eos <100 1. Go to roflumilast (FEV1 < 50% & has chronic bronchitis) OR 1. Azithromycin (former smoker) LABA/LAMA + eos 100+ 1. LABA/LAMA/ICS
38
If a patient is suffering from Exacerbations at FOLLOW-UP (not the initial ABE treatment) what is the algorithm of treatment if on a LABA/LAMA/ICS?
1. Go to roflumilast (FEV1 < 50% & has chronic bronchitis) OR 1. Azithromycin (former smoker)
39
If a patient is suffering from Exacerbations at FOLLOW-UP (not the initial ABE treatment) what is the algorithm of treatment if on a LABA/LAMA/ICS + eos 300+?
Taper OFF ICS dose (12 weeks) - go back to LABA/LAMA
40
What was the outcome of ICS tapering (12 weeks) vs ICS continuing
Tapering did not increase risk of exacerbation - only resulted in a small drop of FEV1 and patient functionality
41
Non-inhaled therapy: Roflumilast Class MOA is it a bronchodilator? Can give as single therapy? Contraindication? Efficacy?
Class: Selective PDE-4 inhibitor MOA - has some anti-inflammatory action is it a bronchodilator? - not a direct bronchodilator Can give as single therapy? - no give with LABA Contraindication - If a patient is losing a lot of weight - Depression Efficacy - improves lung function and reduces exacerbation risk - Does NOT reduce mortality or improve QoL
42
Azithromycin outcome Efficacy Safety
Good for patients who have a smoking history of at least 10 pack-years Efficacy - increased time to first exacerbation - decreased frequency of acute exacerbation Safety - higher rates of hearing loss
43
What vaccines are recommended in COPD patients
- Flu - COVID - Pneumococcal (PCV-20 preferred) - TdaP (tetanus, diphtheria, pertussis) (due to whooping cough) - Shingles (50+) (can get chicken pox in abdomen)
44
What is Alpha-1-Antitrypsin augmentation indicated for?
Young patients with genetic deficiency of emphysema (stiff alveoli)
45
What is vitamin D indicated for in COPD patients?
reduces exacerbations in patients with low baseline levels
46
What are opioids indicated for in COPD patients?
In severe dyspnea when they are in palliative care - causes respiratory drive --> makes them more comfortable instead of gasping for air all the time
47
What type of inhalers use SLOW laminar inspiration and propellant? What type of inhalers use Fast deep strong breath with no propellent?
Slow laminar (aersols) w/ propellant - MDI - Respimat Fast deep strong breath with no propellent - the rest
48
Nebulizer efficacy w salbutamol
- Early benefit at 5 min - No difference at 45 min
49
If you have poor dexterity/coordination, which drug delivery method would you Prefer? Avoid?
Prefer - DPI Avoid - Dry powder capsules - Aerosols (MDI, respimat)
50
If you have poor inspiratory force, which drug delivery method would you Prefer? Avoid?
Prefer (aerosols) - MDI + nebulizer - Respimat Avoid - DPI - Dry powder capsule
51
If you have many puffer types, which drug delivery method would you Prefer? Avoid?
Prefer - turbohalar - MDI - Diskus Avoid - MDI - Dry powder capsule - ellipta - respimat
52
How do you choose an inhaler delivery device within a class?
Solely based on MD & patient preference
53
What bacteria grew in sputum sample of COPD (3) Which are most common
1. H. flu (most common grew) 2. Pseudo aeruginosa (more likely in severe patients) 3. Strep. pneumo
54
What is the strongest predictor of having a future exacerbation
Having a history of exacerbations
54
What are the most common causes of COPD exacerbations? (2)
- having a respiratory tract infection - air pollution
55
Define exacerbation
- increased dyspnea and/or cough + sputum that worsens in less than 14 days - can have tachypnea and/or tachycardia
56
Define mild exacerbations Dyspnea VAS RR HR Resting SaO2 CRP
Dyspnea VAS < 5 RR: < 24 breaths/min HR: <95 bpm Resting SaO2: 92%+ and change <3 CRP: <10mg/L
57
Define moderate exacerbations Meet how many criteria Dyspnea VAS RR HR Resting SaO2 CRP
Meets 3/5 criteria Dyspnea VAS: 5+ RR: 24+breaths/min HR: 95+ Resting SaO2: <92% and change 3%+ CRP: 10+mg/L
58
Define severe exacerbations Dyspnea VAS RR HR Resting SaO2 CRP
Same as moderate ABG show worsening hypercapnia and acidosis (PaCO2 > 45 mmHg and pH <7.35)
59
What are indicators for hospitalization for exacerbations in COPD
- severe symptoms (above) - acute respiratory failure - onset of new symptoms (cyanosis, peripheral edema) - Failure to respond to initial treatment - serious co-morbidites (eg. heart failure - insufficient home support
60
What is the long-term prognosis after hospitalization?
5year mortality rate about 50%
61
What is the initial treatment of COPD exacerbation? what is the discharge from hospital?
Initial: Start SABA and LABA Discharge: LABA and/or LAMA
62
When would you use systemic corticosteroids
When it is interfering with their daily activities - 40mg/day f5d
63
When is antibiotic indicated in COPD exacerbations? (2)
increase in sputum AND - increase in sputum volume OR - increased dyspnea - require mechanical ventilation
64
Which NRT has the fastest onset?
Nicotine spray
65
Which NRT has the most CV side effects
Nicotine patch
66
Bupropion Purpose Safety Benefits
Purpose - reduces withdrawal symptoms Safety - inc seizures, dec appetite (don't use in malnourished patients) Benefits - use if they also have depression
67
Varenicline Purpose Safety
Purpose - reduces withdrawal symptoms - reduces cravings - reduces pleasurable effects of tobacco Safety - only use in stable psychiatric patients
68
Which is more effective - varenicline - buproprion - NRT patch alone
Vareniciline
69
Buproprion is more effective than combo NRT T/F
False - burporion is similar to single NRT, LESS effective than combo NRT
70
What medications are indicated for COVID-19 patients with COPD exacerbations (2)
- systemic steroids - Antibiotics